Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
JPEN J Parenter Enteral Nutr ; 47(1): 41-50, 2023 01.
Article in English | MEDLINE | ID: mdl-35633305

ABSTRACT

BACKGROUND: Steatosis is a common feature of intestinal failure-associated liver disease (IFALD) in adult and older pediatric patients receiving long-term parenteral nutrition (PN). There are limited clinical data concerning steatosis in infants with short bowel syndrome (SBS). We investigated early histopathological steatosis and its association to PN. METHODS: In this retrospective study, 31 patients with SBS had a diagnostic liver biopsy taken at the median age of 5 (IQR 3-8) months. Follow-up biopsy was available for 24 patients at the median age of 29 (IQR 14-52) months. We evaluated the biopsies for steatosis and other histopathological signs of IFALD and compared results with patient characteristics, PN composition, and liver biochemistry. RESULTS: Diagnostic biopsies revealed steatosis in 8 (26%) patients. At the age of 3 months, patients with steatosis had received higher amounts of parenteral glucose: median 15.1 (IQR 12.4-17.2) vs 12.3 (8.7-14.4) g/kg/d (P = 0.04), amino acids: 2.9 (2.5-3.4) vs 2.2 (1.6-2.7) g/kg/d (P = 0.03), and energy: 87 (80-98) vs 73 (54-79) kcal/kg/d (P = 0.01) than those without steatosis. We detected no significant differences in parenteral lipid intake between the groups. Steatosis also associated with increased serum bile acid (P = 0.02), alanine aminotransferase (P = 0.0002), and aspartate aminotransferase (P = 0.001) levels. CONCLUSIONS: In this cohort, high parenteral glucose, amino acid, and energy provision associated with liver steatosis in infants with SBS. We recommend monitoring of bile acid and transaminase levels while aiming for PN with balanced macronutrient supply according to current recommendations to protect the liver from steatosis.


Subject(s)
Fatty Liver , Intestinal Diseases , Liver Diseases , Liver Failure , Short Bowel Syndrome , Adult , Humans , Infant , Child , Child, Preschool , Short Bowel Syndrome/complications , Short Bowel Syndrome/therapy , Amino Acids , Retrospective Studies , Fatty Liver/etiology , Fatty Liver/diagnosis , Parenteral Nutrition/adverse effects , Intestinal Diseases/therapy , Liver Failure/complications , Bile Acids and Salts
2.
Sci Rep ; 12(1): 17516, 2022 10 20.
Article in English | MEDLINE | ID: mdl-36266329

ABSTRACT

Children with short bowel syndrome (SBS) are at high risk for intestinal failure associated liver disease (IFALD). The aim of this retrospective follow-up study was to compare weaning off parenteral nutrition (PN) and IFALD between necrotizing enterocolitis (NEC) and non-NEC induced SBS. Altogether, 77 patients with neonatal SBS treated by our multidisciplinary intestinal failure unit (NEC n = 38, non-NEC SBS n = 39) were included and followed-up at least for 2 years until median age of 10 years (interquartile range, 6.0-16). Occurrence and characteristics of IFALD was assessed with liver biopsies obtained at median age of 3.2 (1.0-6.7) years (n = 62) and serum liver biochemistry. Overall, NEC patients had less end-jejunostomies and autologous intestinal reconstruction surgeries performed compared to non-NEC patients (< 0.05), while remaining small bowel anatomy was comparable between groups. Cumulative weaning off PN was more frequent and duration of PN shorter among NEC patients (P < 0.05). Overall cumulative probability of histological IFALD was lower among NEC patients during whole follow-up period (P = 0.052) and at 10 years (P = 0.024). NEC patients had lower ALT and GGT levels at last follow-up (P < 0.05 for all). In univariate Cox regression analysis, absence of end-jejunostomy, NEC diagnosis, longer remaining small bowel length, multidisciplinary treatment and prematurity were predictive for weaning off PN, while NEC diagnosis and lower birth weight in addition to multidisciplinary care protected from histological IFALD. Neonates with NEC induced SBS reached enteral autonomy earlier than those with non-NEC SBS, which associated with more efficient resolution of histological IFALD among long-term survivors.


Subject(s)
Enterocolitis, Necrotizing , Fetal Diseases , Infant, Newborn, Diseases , Intestinal Diseases , Liver Diseases , Liver Failure , Short Bowel Syndrome , Humans , Infant, Newborn , Child , Female , Child, Preschool , Short Bowel Syndrome/complications , Short Bowel Syndrome/therapy , Enterocolitis, Necrotizing/therapy , Enterocolitis, Necrotizing/complications , Follow-Up Studies , Retrospective Studies , Intestinal Diseases/complications , Liver Failure/complications , Liver Diseases/complications
3.
J Pediatr Gastroenterol Nutr ; 70(1): 64-71, 2020 01.
Article in English | MEDLINE | ID: mdl-31651669

ABSTRACT

OBJECTIVE: The impact of pediatric intestinal failure (IF) on neurodevelopment beyond infancy has not been systematically studied. Our aim was to evaluate cognitive and motor impairment and to identify risk factors for adverse outcomes among children with IF. METHODS: We conducted a cross-sectional single-center study at the Helsinki University Children's Hospital. Patients with IF with >60 days of parental nutrition (PN) dependency aged between 3 and 16 years (n = 40) were invited to participate. The cognitive and motor skills were evaluated using validated tests: Wechsler Preschool and Primary Scale of Intelligence, 3rd edition, Wechsler Intelligence Scale for Children, 4th edition, and Movement Assessment Battery for Children, 2nd edition. RESULTS: All the patients attending the study tests (n = 30, males = 24) were included. Their median age, gestational age, and birth weight was 7.5 (range 3-16) years, 35 (interquartile range [IQR] 28-38) weeks and 2238 (IQR 1040-3288) grams, respectively. Median duration of PN was 13 (IQR 5-37) months and 9 patients were currently on PN. Median intelligence quotient was 78 (IQR 65-91) and 10 (35%) patients had an intelligence quotient under 70 (-2 standard deviation). Significant motor impairment was detected in 10 patients (36%) and milder difficulties in 8 (28%). Adverse cognitive outcome was associated with neonatal short bowel syndrome, number of interventions under general anesthesia, and length of inpatient status, whereas adverse motor outcome was associated with prematurity. CONCLUSION: Clinically significant cognitive and motor impairments are alarmingly common among neonatal patients with IF. We recommend early neurodevelopmental follow-up for all children with IF.


Subject(s)
Cognition Disorders/etiology , Infant, Premature, Diseases/psychology , Infant, Premature/psychology , Motor Skills Disorders/etiology , Short Bowel Syndrome/psychology , Adolescent , Birth Weight , Child , Child Development , Child, Preschool , Cognition , Cross-Sectional Studies , Female , Gestational Age , Humans , Infant, Newborn , Infant, Premature, Diseases/physiopathology , Intelligence Tests , Male , Motor Skills , Parenteral Nutrition , Risk Factors
4.
JPEN J Parenter Enteral Nutr ; 42(7): 1203-1210, 2018 09.
Article in English | MEDLINE | ID: mdl-29701873

ABSTRACT

BACKGROUND: Essential fatty acid (EFA) status may be compromised during the intestinal failure (IF) rehabilitation. Parenteral lipid restriction is used to treat intestinal failure associated liver disease (IFALD), while the enteral fatty acid (FA) absorption remains limited. We analyzed the FA status among pediatric IF and intestinal insufficiency patients. METHODS: We evaluated 49 patients aged 0-18 years attending our nationwide IF referral center. Their serum FA fractions were determined and examined against previous nutrition, parenteral lipid emulsion, and intestinal anatomy data. The patients were divided into 3 subgroups according to their dependence on parenteral nutrition (PN): full enteral (EN) (n = 33), supplemental PN (n = 14) or predominantly PN (n = 20). Trien:tetraen ratio (TTR) ≥0.2 was considered diagnostic for essential fatty acid deficiency (EFAD) and increased risk was suspected if TTR exceeded 0.1. RESULTS: We identified 8 (16%) patients with elevated TTR ≥0.1; in 3 of them the ratio exceeded 0.2. Five of these children belonged to supplemental PN group. This group carried the highest incidence of elevated TTR (P = 0.0016), with median TTR at 0.06 (interquartile range 0.03-0.09) and two-thirds of the analyzed TTR ≥0.5. Increased EFAD risk was associated with young age (P = 0.0291), current PN with low parenteral lipid content (P = 0.0003), and short remaining small bowel (P = 0.0013). CONCLUSIONS: IF children with supplemental PN carry the highest overall risk for EFAD. Young age, current PN, and short remaining small bowel also increase the risk for EFAD.


Subject(s)
Deficiency Diseases/etiology , Fatty Acids, Essential/deficiency , Intestinal Diseases/therapy , Intestines/pathology , Lipids/administration & dosage , Nutritional Status , Parenteral Nutrition/adverse effects , Child , Child, Preschool , Deficiency Diseases/epidemiology , Enteral Nutrition , Ethylenediamines/blood , Fat Emulsions, Intravenous , Fatty Acids, Essential/blood , Female , Humans , Infant , Infant, Newborn , Intestinal Diseases/blood , Intestinal Diseases/complications , Intestine, Small/pathology , Lipids/blood , Lipids/deficiency , Male , Pediatrics , Prevalence , Risk Factors , Short Bowel Syndrome , Trientine/blood
5.
Nutrition ; 45: 90-93, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29129242

ABSTRACT

OBJECTIVE: Although impaired renal function has been a frequent finding among adults with intestinal failure (IF), the data on children is scarce. The aim of this study was to assess renal function in pediatric-onset IF. METHODS: Medical records of 70 patients (38 boys) with pediatric-onset IF due to either short bowel syndrome (n = 59) or primary motility disorder (n = 11) and a history of parenteral nutrition (PN) dependency for ≥1 mo were evaluated. Renal function at the most recent follow-up was studied using plasma creatinine, cystatin C, and urea concentrations and estimated glomerular filtration rate (eGFR). RESULTS: At a median age of 5.7 y and after PN duration of 3.2 y, 20 patients (29%) had decreased eGFR and higher cystatin C and urea concentrations. Patients with decreased renal function had significantly longer duration of PN (3.2 versus 0.9 y; P = 0.030) and shorter percentage of age-adjusted small bowel length remaining (22 versus 32%; P = 0.041) compared with patients with preserved renal function. No other predisposing factors for decreased eGFR were identified. CONCLUSIONS: Patients with pediatric-onset IF are at significant risk for impaired renal function, which is associated with the duration of PN and the length of the remaining small bowel. In the present study, no other predisposing factors for decreased eGFR were found. Further studies using measured GFR are needed.


Subject(s)
Intestinal Diseases/blood , Renal Insufficiency/blood , Adolescent , Child , Child, Preschool , Creatinine/blood , Cystatin C/blood , Female , Follow-Up Studies , Glomerular Filtration Rate , Humans , Intestinal Diseases/complications , Intestines/physiopathology , Male , Parenteral Nutrition , Renal Insufficiency/etiology , Risk Factors , Urea/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...